Skip to main content
National AETC Support Center (NASC)
Homepage
  • Log in
Main navigation
  • About
    • About the AETC Program
    • ShareSpot: The AETC Blog
    • Quarterly Newsletter
    • Contact Us
    • AETC Program Members
  • Training
    • Training Overview
    • National HIV Curriculum
    • National RWHAP Clinical Conference
    • Residency Programs
    • Preceptorships
    • Self-Directed Learning
    • Webinar Recordings
  • Consultation
    • Consultation Overview
    • Request Technical Assistance
  • Directory
    • AETC Program Map
    • Regional Offices
    • National Centers
    • AETC Program Initiatives
  • Resources
    • Explore Resources
    • Topic index
    • HIV Care Tools App
  • Calendar

File 3 of 5 from HIV and HCV Drug Interactions: Quick Guides for Clinicians

Back to HIV and HCV Drug Interactions: Quick Guides for Clinicians page
Download
previous file: (Glecaprevir/Pibrentasvir (Mavyret™) Drug Interactions)
1
2
3
4
5
next file: (Sofosbuvir/Velpatasvir (Epclusa®) Drug Interactions)

Ledipasvir/Sofosbuvir (Harvoni®) Drug Interactions

Footer menu

  • Members
  • Contact
  • Subscribe
  • Policies
  • Login

Keep in touch

  • Facebook
  • Twitter
  • YouTube
  • Linked In
  • Instagram
  • Flickr
  • Podcast

Apple Store Google Play

Footer Content

François-Xavier Bagnoud CenterUniversity of California San Francisco Center for HIV Information

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award (grant number U10HA49824) totaling $1,915,000 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.